Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.

Abstract

Universal prenatal screening for GBS and chemoprophylaxis of colonized women with labor complications is likely to be cost-beneficial in the United States. Development of alternative strategies should be further explored for populations in which GBS screening is impractical. Continued development of a GBS vaccine is an important public health priority.